Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Another Record Quarter and a Record Year for NuSkin !!

|Includes:Nu Skin Enterprises Inc. (NUS)

bold emphasis mine. 

NuSkin Enterprises Reports Record 4th Quarter and 2010 Results PROVO, Utah, Feb. 2, 2011 /PRNewswire/ -- NuSkin Enterprises, Inc.,(NYSE: NUS) today announced record fourth-quarter and annual results. Revenue for the quarter was $401.2 million, a 6 percent improvement over the prior year. Earnings per share for the quarter increased 23 percent to $0.58, compared to $0.47 in the prior year.

The company also reported record annual revenue of $1.54 billion, a  15 percent year-over-year improvement. Earnings per share for the year  were $2.11, a 51 percent increase over 2009.

"2010 was an exceptional year for Nu Skin as we generated a record level of revenue, paid out a record level of commissions to our sales leaders, and enjoyed a record level of profitability," said Truman Hunt, president and chief executive officer. Our growth is a reflection of the compelling innovation we have  infused into our ageLOC product platform, as well as our sales leaders' phenomenal ability to bring this innovation to the marketplace.

"We concluded the year with our first-ever $400 million-dollar revenue quarter,
which is an exciting benchmark in our effort to become the world's leading direct
selling company. And our global management team continues to execute successfully on our growth initiatives, boosting operating margin for the year by approximately 220 basis points to 14.1 percent. From virtually every metric, 2010 was a highly successful year," said Hunt.

Outlook

"We anticipate another record year in 2011 as we expand our ageLOC  story to address aging from the inside of the body," said Hunt.  Overall, the strength of our ageLOC platform, the significant opportunity we see in emerging markets and our continued focus on improving profitability will enable us to sustain long-term growth.
------------------------------------------------------------------
And while the initial market reaction was unfavorable in the short run - the fundamentals of the company and industry remain strong.  I remain long NUS.

Live With Intention,
DrBillToth.com/blog
 



 
Stocks: NUS